Skip to content
value.today

Relation Therapeutics Inc.

🇺🇸 Lauderhill, Florida, USABiotechnologyFounded 2021
Total raised
$49 M
2 rounds on record
Latest round
$40 M
Jan 2024
First round on record
Jul 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Relation Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2024$40 MNo. 2$10 to $50 million

Relation Therapeutics Inc.: Raise no. 2, Jan 2024

Investors in this round

10 investors had bought by the notice of Jan 19, 2024: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Relation Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$40 M of $52 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Casey Swerner · Executive Officer
  • David Roblin · Executive Officer, Director
  • Charles Roberts · Director
  • Christine Aylward · Director
  • Jason Pontin · Director
  • Jim Mellon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Casey Benjamin Swerner, President. Source: SEC Form D, newest notice filed Jan 19, 2024. Read the notice at the SEC.

equitySEC
Jul 2021$9 MNo. 1$2 to $10 million

Relation Therapeutics Inc.: Raise no. 1, Jul 2021

Investors in this round

10 investors had bought by the notice of Aug 10, 2021: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Relation Therapeutics Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Casey Benjamin Swerner · Executive Officer
  • Charles Roberts · Director
  • David Roblin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Casey Benjamin Swerner, President. Source: SEC Form D, newest notice filed Aug 10, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Relation Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2024).

    SEC Form D · Jan 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2024

That is all the official record says: Relation Therapeutics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in Relation Therapeutics Inc.
InvestorKindAmountRoundRoleSource
ARK Venture FundFund or asset manager$3 Mheldnot statedHolds shares (fund report, Jul 2026)SEC Form N-PORT

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Relation Therapeutics Inc.
NameRoleNamed in
Casey SwernerExecutive officerJan 2024
David RoblinExecutive officerJan 2024
Casey Benjamin SwernerExecutive officerAug 2021
Charles RobertsDirectorJan 2024
Christine AylwardDirectorJan 2024
David RoblinDirectorJan 2024
Jason PontinDirectorJan 2024
Jim MellonDirectorJan 2024